InsidersTradesSigma
BioGaia AB: insider trades · Finland · FIN-FSA
FI:biogaia-abSE0017769995FI·FIN-FSAMcap 13.2Bn€Healthcare
Discover the full management transaction log of BioGaia AB, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, BioGaia AB has published 10 reports. Market capitalisation: €13.2bn. The latest transaction was filed on 13 February 2026 — Purchase. Among the most active insiders: Anthon Jahreskog. All data is openly available.
10
Insider Decl.
0
Thresholds
€100,356
9 ops.
Buy Volume
€199
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
130.00 €
Analyst consensus
1 analystsStrong buy
165.00 €Target 165.00 €(+27%)165.00 €
Income statement
Revenue1.54 Bn€
Gross profit1.13 Bn€73% margin
Net income332.8 M€21.5% margin
Valuation
PER (trailing)39.6x
PER (forward)26.1x
P/Book9.4x
Balance sheet & cash
Market cap13.15 Bn€
Total debt10.4 M€
Free Cash Flow303.0 M€
Profitability & ownership
ROE20.9%
ROA15.3%
% insiders16.1%
% institutions60.4%
Last declaration on 13 February 2026
Declarations10 total
Executives●Purchase20FIN-FSA
€5,475582 shares@ €9.40720.0000% mcap100.0% of flow
Aktie
FI:A003V922-1·
Ideal exit: 10 Nov 2026 (T+270)
Executives●Purchase23FIN-FSA
€44,6375,000 shares@ €8.92740.0003% mcap75.8% of flow
Aktie
FI:A003U454-1·
Ideal exit: 1 Sept 2026 (T+270)
Executives●Purchase29FIN-FSA
€17,8002,000 shares@ €8.90010.0001% mcap49.2% of flow
Aktie
FI:A003U448-1·
Ideal exit: 1 Sept 2026 (T+270)
Executives●Purchase29FIN-FSA
€18,3752,000 shares@ €9.18740.0001% mcap50.8% of flow
Aktie
FI:A003U235-1·
Ideal exit: 25 Aug 2026 (T+270)
Executives●Purchase17FIN-FSA
€12,6811,380 shares@ €9.18940.0001% mcap21.5% of flow
Aktie
FI:A003U222-1·
Ideal exit: 24 Aug 2026 (T+270)
Executives●Purchase12FIN-FSA
€30735 shares@ €8.76910.0000% mcap0.5% of flow
Aktie
FI:A003T395-1·
Ideal exit: 4 Aug 2026 (T+270)
Executives●Sale12FIN-FSA
€19920 shares@ €9.97420.0000% mcap0.3% of flow
Aktie
FI:A003T026-1·
Executives●Purchase12FIN-FSA
€1,081112 shares@ €9.64760.0000% mcap1.8% of flow
Aktie
FI:A003O363-1·
Ideal exit: 9 Feb 2026 (T+270)
Executives●Purchase12FIN-FSA
020,000 shares0
Option
FI:A003M272-1·
Ideal exit: 2 Dec 2025 (T+270)
Executives●Purchase12FIN-FSA
035,000 shares0
Option
FI:A003M159-1·
Ideal exit: 29 Nov 2025 (T+270)
10 of 10 declarations